The University of Oxford in the UK has reported positive findings of its Covid-19 vaccine candidate in a small preclinical study involving six monkeys.
These preliminary data of the vaccine, which is currently in human trials, have been published on the preprint website bioRxiv, noted Reuters.
According to the publication, some of the monkeys administered with a single shot of the vaccine generated antibodies against the virus within 14 days while all monkeys developed antibodies within 28 days, prior to being exposed to high virus doses.
Following exposure to the coronavirus, the vaccine candidate was observed to prevent damage to the lungs and blocked the virus from replication.